December update at DEBX Medical
December 28, 2023
February update at DEBX Medical
February 29, 2024
January update at DEBX Medical
January 31, 2024 News
Exciting Start to 2024!

Highlight at Journées Cicatrisations 2024
DEBRICHEM® was a standout topic at Journées Cicatrisations 2024, hosted by Société Française de Formation en Plaies et Cicatrisation (SFFPC).
This important conference took place from January 21 to January 23, 2024, at the Palais des Congrès in Paris, France. Our participation, alongside Longuy Medical Devices, marked a strong start to this year.
Journées Cicatrisations serves as a key gathering for professionals in wound care and stands out for its specialized focus, comprehensive program, practical learning opportunities, and strong emphasis on innovation.


Global Engagement and Future Plans
CEO Bert Quint engaged with global healthcare leaders at the Arab Health Conference in Dubai, UAE.
Arab Health Conference 2024 took place from January 29 to February 1, 2024. It is a major healthcare event held annually in Dubai, UAE and is one of the largest healthcare exhibitions and conferences in the Middle East.
Looking ahead, we’re preparing for the 15th Abu Dhabi Wound Conference in March and EWMA 2024 in May.

Bert and Tristan at Arab Health 2024, Dubai



DEBRICHEM® Abstract in Military Health System Research Symposium (MHSRS)
Another significant step forward this month was abstract submission to MHSRS. MHSRS is a premier symposium of US’ Department of Defense. It focuses on cutting-edge research and key advancements in military medicine and health. The event will take place from August 26 to August 29, 2024, at the Gaylord National Resort & Convention Center in Kissimmee, Florida.


Exciting Developments Ahead
DEBRICHEM® is revolutionizing wound care every step of the way. Stay tuned for more updates or follow us on LinkedIn for the latest news! https://lnkd.in/eUdBM2U7

January update at DEBX Medical
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.